Trade EPRX stock anytime, 24x5 in Singapore
Regulated by
Monetary Authority of Singapore (MAS)
Trusted by
400,000+ users
Eupraxia Pharmaceuticals Inc. (EPRX) is trading at US$8.07, down 4.16% today as of Sep 14, 16:00 EDT. The company has a market capitalisation of US$443.55M. Over the past 52 weeks, EPRX has traded between US$5.16 and US$9.32. On Syfe you can trade EPRX with $0 commission and add it to your watchlist.
| Previous close | US$8.42 |
|---|---|
| Market cap | US$443.55M |
| 52-week range | US$5.16 – US$9.32 |
| Volume | 431.55K |
| Exchange | US |
Add to Watchlist
Set Price Alert
Eupraxia Pharmaceuticals Inc.
Eupraxia Pharmaceuticals, Inc. operates as a drug delivery technology company in Canada. It delivers drugs into body compartments, such as the joint without any of the common issues with body compartment injections, such as systemic exposure. The firm focuses on arthritis, diabetic macular edema, and chronic pain programs. The company was founded by James A. Helliwell, John Salvatore Montalbano and Amanda Malone on May 12, 2011 and is headquartered in Victoria, Canada.
Year: 2021
Top Premarket Decliners
Jul 28, 11:29 AM · MT Newswires
Stifel Initiates Eupraxia Pharmaceuticals at Buy With CA$34.37 Price Target
May 21, 11:06 AM · MT Newswires
Eupraxia Pharmaceuticals Reports 'Robust Response' for EP-104GI Trial to Treat Esophageal Disease
Apr 21, 12:47 PM · MT Newswires
Eupraxia Pharmaceuticals Inc. (EPRX) stock is trading at US$8.07, -4.16% from the previous close of US$8.42.
The market cap for Eupraxia Pharmaceuticals Inc. (EPRX) stock is approximately US$443.55M.
The 52-week high for Eupraxia Pharmaceuticals Inc. (EPRX) stock is US$9.32.
The 52-week low for Eupraxia Pharmaceuticals Inc. (EPRX) stock is US$5.16.
Eupraxia Pharmaceuticals Inc. (EPRX) does not currently pay a dividend.
Stay on top of EPRX
Price moves, news and earnings — straight to your inbox.
Est. order value
US$0.00
Snapshot
Popular Stocks in Singapore
